Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal Squamous Cell Cancer

NCT07016724 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

208

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

COMBINATION_PRODUCT: cadonilizumab combined with neoadjuvant radiochemotherapy
COMBINATION_PRODUCT: neoadjuvant radiochemotherapy

Sponsor

The First Affiliated Hospital of Zhengzhou University